Join Now

Author Archives: Denise Bell

Sanofi Commits $1M to Support Parkinson’s Disease Genetic Research

By Denise Bell | Published October 23, 2020

Sanofi and the Parkinson’s Foundation announced on Wednesday a new research collaboration to advance the availability of genetic testing and counseling for people with Parkinson’s disease in the U.S. Over the next two years, Sanofi will provide $1 million in research funding to support the PD GENEration Mapping the Future of Parkinson’s Disease initiative. The […]

Posted in BioUtah COVID-19 Analysis, COVID-19 Updates, Featured Members, Federal News, Life Sciences Industry News, Policy News | Leave a comment

SBA Extends PPP Loan Deferral, New Streamlined Forgiveness for Loans of $50,000 or Less

By Denise Bell | Published October 16, 2020

On October 7, the SBA released updated FAQs (question #52) to clarify that lenders must recognize the extended deferral period for payments on the principal, interest, and fees on all PPP loans, even if the initial loan terms indicates a six-month deferral (the initial period when the program was first enacted). Under the Paycheck Protection […]

Posted in COVID-19 Legislation, COVID-19 Updates, Federal News, Policy News | Leave a comment

IDbyDNA and Illumina Launch New Rapid Test to Better Detect COVID-19, Flu, Respiratory Co-Infections

By Denise Bell | Published October 16, 2020

Utah-based IDbyDNA announced yesterday that, in an effort to help labs better identify respiratory pathogens and avoid overuse of antimicrobial drugs, IDbyDNA and Illumina, Inc. are co-launching the new Respiratory Pathogen ID/AMR Target Enrichment Assay. The test, currently for research use only, will improve testing for infectious diseases, including COVID-19, and will leverage IDbyDNA’s Explify® […]

Posted in BioUtah News, COVID-19 Updates, Life Sciences Industry News, Press Releases, State News, Utah's Life Sciences Companies | Leave a comment

SDP Oncology Announces First Patient Dosed in a Phase 1 Solid Tumor Study

By Denise Bell | Published October 16, 2020

Lehi-based Sumitomo Dainippon Pharma Oncology (SDP Oncology) recently announced that the first patient has been dosed with the PKM2 activator, TP-1454, in a Phase 1/1b study in patients with advanced metastatic or progressive solid tumors.  “Dosing the first patient in this study marks an important milestone, as TP-1454 is the first PKM2 activator to be […]

Posted in BioUtah News, Featured Members, Life Sciences Industry News, State News, Utah's Life Sciences Companies | Leave a comment

Governor Herbert Announces New COVID-19 Transmission Index

By Denise Bell | Published October 16, 2020

On Wednesday, Governor Herbert announced the state’s new response plan to COVID-19, effective October 15. This updated plan utilizes a COVID-19 Transmission Index and replaces the previous color-coded guidance system of red, orange, yellow and green. The new approach comes at a time when the state has seen a significant spike in infection rates. The […]

Posted in BioUtah News, Business Tools & Resources, COVID-19 Updates, State News, Utah's Life Sciences Companies | Leave a comment

Sumitomo Dainippon Pharma Oncology Announces First Patient Dosed with TP-1454 in Patients with Advanced Solid Tumors 

By Denise Bell | Published October 14, 2020

CAMBRIDGE, Mass., October 9, 2020 – Sumitomo Dainippon Pharma Oncology, Inc., a developer of novel cancer therapeutics, today announced that the first patient has been dosed with TP-1454, an investigational small-molecule pyruvate kinase M2 isoform (PKM2) activator, administered alone and in combination with ipilimumab and nivolumab, in a Phase 1/1b study in patients with advanced […]

Posted in BioUtah News, Industry News, Life Sciences Industry News | Leave a comment

Pediatric Rare Disease Voucher Program Extended

By Denise Bell | Published October 9, 2020

Congress recently provided a short-term extension until December 11 of the Rare Pediatric Disease Priority Review Voucher program. The program was set to expire on September 30, but was given a reprieve in the Continuing Appropriations Act, 2021 and Other Extensions Act (H.R. 8337) that kept the government funded. Congress will have to act again […]

Posted in Federal News, Industry News, Policy News | Leave a comment

SINTX Technologies Develops New Mask Fabric with Silicon Nitride

By Denise Bell | Published October 9, 2020

On Tuesday, SINTX Technologies (SINTX) announced progress toward the manufacture of a “catch-and-kill” mask that will inactivate respiratory viruses. SINTX has successfully embedded silicon nitride particles into nonwoven and woven fabric fibers. Silicon nitride has been shown to neutralize several bacterial species and viral strains, including SARS-CoV-2.  “By investing in our human resources and equipment, […]

Posted in BioUtah News, State News, Utah's Life Sciences Companies | Leave a comment

Mountain Pacific Venture Fund Invests in SLC Laparoscopic Device Company Xenocor

By Denise Bell | Published October 9, 2020

Utah-based Mountain Pacific Venture Fund (MPVF) announced on Monday an investment in Xenocor, a Salt Lake City-based medical device company that has developed the XenoscopeTM, a single-use, multi-purpose HD laparoscope with an integrated light source. Designed to be fog proof, the Xenoscope minimizes common visualization challenges and provides consistent image quality through electrocautery smoke. MPVF’s […]

Posted in BioUtah News, Funding, Industry News, Life Sciences Industry News, Utah's Life Sciences Companies | Leave a comment

Johnson & Johnson Signs Communiqué on Expanded Global Access for COVID-19

By Denise Bell | Published October 9, 2020

Johnson & Johnson recently announced that it’s joined 15 other companies in signing a Communiquie on Expanded Global Access to ensure that people everywhere – regardless of their income level – have access to COVID-19 vaccines, therapeutics and diagnostics under development at these companies.  Each of the signing companies—AstraZeneca; Bayer; bioMérieux; Boehringer Ingelheim; Bristol Myers […]

Posted in COVID-19 Updates, Industry News | Leave a comment

U OF U Establishes Partners For Innovation, Ventures, Outreach & Technology

By Denise Bell | Published October 9, 2020

U of U President Ruth V. Watkins announced on September 30 that the U has formed the Partners for Innovation, Ventures, Outreach & Technology (PIVOT) Center. This new centralized office builds on the work by the Center for Technology & Venture Commercialization (TVC) and will facilitate the U’s efforts to drive technology commercialization and economic […]

Posted in BioUtah News, State News, Utah's Life Sciences Companies | Leave a comment

Utah Business Magazine Recognizes Recursion’s Tina Larson, Civica’s Heather Wall Among Utah’s Top C-Suite Executives

By Denise Bell | Published October 2, 2020

Recursion’s President and Chief Operating Officer, Tina Larson, and Civica’s Chief Commercial Officer, Heather Wall, were recently recognized by Utah Business Magazine as among Utah’s top C-Suite executives. In introducing the 2020 CXO of the Year honorees, the magazine notes that “now more than ever we need strong leaders to guide our businesses forward and […]

Posted in BioUtah News, Industry News, Life Sciences Industry News, State News, Utah's Life Sciences Companies | Leave a comment

A Special Thanks To Our Elite Members